Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Maltoni

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Dental Cadmos|December 15, 1988
[Ergonomic furnishing and layout of the dental office]P Lavano, R Maltoni
Dental Cadmos|July 15, 1988
[Back problems and bad postural habits]P Lavano, R Maltoni
Chirurgia Italiana|January 1, 1995
[Role of biological indicators in the therapeutic decision in breast carcinoma]D Amadori, R Maltoni
Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Evaluation of toxicity in 22 patients treated with subcutaneous interleukin-2, alpha-interferon with and without chemotherapyR Ridolfi, R Maltoni, A Riccobon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
EAP in advanced gastric cancerR Ridolfi, D C Giunchi, M Amadori, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patientsM Maltoni, O Nanni, S Derni, et al.
Tumori|April 25, 2000
Tumor infiltrating lymphocytes and continuous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinomaM Fabbri, R Ridolfi, R Maltoni, et al.
Oncology|November 16, 2007
Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studiesA Passardi, R Maltoni, C Milandri, et al.
Tumori|November 1, 1995
Liver metastases from gastric carcinoma: report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2)L Fabbri, R Ridolfi, A Riccobon, et al.
Breast Cancer Research and Treatment|November 2, 2001
Biomarker prediction of clinical outcome in operable breast cancer patients treated with tamoxifenE Scarpi, F De Paola, M Sarti, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Dental Cadmos|December 15, 1988
[Ergonomic furnishing and layout of the dental office]P Lavano, R Maltoni
Dental Cadmos|July 15, 1988
[Back problems and bad postural habits]P Lavano, R Maltoni
Chirurgia Italiana|January 1, 1995
[Role of biological indicators in the therapeutic decision in breast carcinoma]D Amadori, R Maltoni
Journal of Chemotherapy (Florence, Italy)|December 1, 1992
Evaluation of toxicity in 22 patients treated with subcutaneous interleukin-2, alpha-interferon with and without chemotherapyR Ridolfi, R Maltoni, A Riccobon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
EAP in advanced gastric cancerR Ridolfi, D C Giunchi, M Amadori, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patientsM Maltoni, O Nanni, S Derni, et al.
Tumori|April 25, 2000
Tumor infiltrating lymphocytes and continuous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinomaM Fabbri, R Ridolfi, R Maltoni, et al.
Oncology|November 16, 2007
Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studiesA Passardi, R Maltoni, C Milandri, et al.
Tumori|November 1, 1995
Liver metastases from gastric carcinoma: report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2)L Fabbri, R Ridolfi, A Riccobon, et al.
Breast Cancer Research and Treatment|November 2, 2001
Biomarker prediction of clinical outcome in operable breast cancer patients treated with tamoxifenE Scarpi, F De Paola, M Sarti, et al.
Pageof 2